Jianglin Liang

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 207 citations · Full text

Influenza Pb2, Medicinal Chemistry, Medicine +13

Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)

Jon H. Come, Philip N. Collier, James A. Henderson et al. · Journal of Medicinal Chemistry · 2018 · 46 citations · Full text

Immunology, Pharmacotherapy, Pharmaceutical Chemistry +20

CsF-Mediated in Situ Desilylation of TMS-Alkynes for Sonogashira Reaction

Joseph S. Capani, John E. Cochran, Jianglin Liang · The Journal of Organic Chemistry · 2019 · 34 citations

Volatile Alkynes, Asymmetric Catalysis, Chemical Engineering +10

A Model Study toward the Total Synthesis of <i>N</i>-Deacetyllappaconitine

Douglass F. Taber, Jianglin Liang, Bei Chen et al. · The Journal of Organic Chemistry · 2005 · 33 citations

Development of a Scalable Synthesis of an Azaindolyl-Pyrimidine Inhibitor of Influenza Virus Replication

Jianglin Liang, John E. Cochran, Warren A. Dorsch et al. · Organic Process Research & Development · 2016 · 20 citations

Viral Replication, Synthetic Virology, Molecular Biology +19